Can metoclopramide (Reglan) be used during pregnancy?

Yes, metoclopramide (Reglan) can be used safely during pregnancy

Metoclopramide is safe and effective for treating nausea and vomiting in pregnancy and should be used as a second-line antiemetic when first-line agents (antihistamines, phenothiazines, or doxylamine/pyridoxine) are ineffective 1.

Safety Profile in Pregnancy

The FDA classifies metoclopramide as Pregnancy Category B, meaning animal reproduction studies have shown no harm to the fetus at doses 12-250 times the human dose, though adequate controlled studies in pregnant women are lacking 2. However, extensive real-world evidence strongly supports its safety:

• No increased risk of major congenital malformations: A large Danish cohort study of 28,486 first-trimester exposures found no association with malformations overall (OR 0.93,95% CI 0.86-1.02) or any of 20 specific malformation categories assessed 3

• No increased risk of fetal death: The same study found no increased risk of spontaneous abortion (HR 0.35) or stillbirth (HR 0.90) 3

• Consistent safety data across multiple studies: A meta-analysis of 33,374 exposed infants confirmed no significant increase in major malformations (OR 1.14,95% CI 0.93-1.38) 4, and an Israeli cohort of 3,458 exposures showed similar reassuring results 5

Positioning in Treatment Algorithm

When to Use Metoclopramide:

1. First-line options fail: Start with antihistamines (e.g., doxylamine), phenothiazines (e.g., promethazine), or doxylamine/pyridoxine combination 1

2. Second-line therapy: Use metoclopramide alone or in combination with other antiemetics when first-line agents are ineffective 1

3. Can be used throughout pregnancy: Safe for both nausea/vomiting of pregnancy (NVP) and hyperemesis gravidarum (HG)

Critical Safety Considerations

Extrapyramidal Side Effects (Most Important Risk):

Metoclopramide carries risk of extrapyramidal reactions, which must be managed carefully 1:

• Administer IV doses slowly: Give over at least 3 minutes to minimize acute dystonic reactions 1

• Watch for acute dystonia: Can occur early in treatment, including oculogyric crisis (upward eye deviation) 6. More common in young adults and children

• Limit duration: Do not use for more than 12 weeks due to risk of tardive dyskinesia (irreversible involuntary movements) 2

• Screen for prior reactions: Always ask about previous adverse reactions to metoclopramide before prescribing 1

• Treatment of dystonia: If acute dystonia occurs, give trihexyphenidyl (benzhexol) or diphenhydramine and stop metoclopramide immediately 6

Emerging Concern - Depressive Symptoms:

Recent 2026 data suggests metoclopramide may cause depressive symptoms more frequently in pregnant women (21.1% in pregnancy vs 3.0% in non-pregnant women, ROR 8.6) 7. Notably:

• 33.3% of pregnancy-related cases involved suicidal ideation 7
• Often accompanied by anxiety, panic attacks, agitation, and restlessness 7
• Screen for mood changes and suicidal thoughts when prescribing metoclopramide in pregnancy
• Stop immediately if depressive symptoms emerge

Practical Prescribing Details

Dosing:

• Standard dose: 10 mg orally, intramuscularly, or intravenously
• Frequency: Three to four times daily, typically 30 minutes before meals and at bedtime
• IV administration: Must give slowly over at least 3 minutes 1

Route Selection:

• Intravenous route most studied and effective for acute symptoms
• Oral route appropriate for ongoing management
• All routes appear effective when patient can tolerate them

Drug Interactions in Pregnancy:

• Insulin dosing may need adjustment: Metoclopramide speeds gastric emptying, potentially causing hypoglycemia in diabetic patients 2
• Avoid with MAO inhibitors (releases catecholamines) 2
• Effects antagonized by anticholinergics and narcotics 2

Common Pitfalls to Avoid

1. Using as first-line: Always try antihistamines or phenothiazines first per guidelines 1

2. Rapid IV administration: This increases dystonia risk—always give over ≥3 minutes 1

3. Prolonged use beyond 12 weeks: Increases tardive dyskinesia risk 2

4. Ignoring mood changes: New evidence suggests heightened risk of depression/suicidality in pregnancy—monitor closely 7

5. Not counseling about extrapyramidal symptoms: Patients should know to report involuntary movements, muscle spasms, or mood changes immediately

Breastfeeding Considerations

Metoclopramide is excreted in breast milk 2. While the FDA label states "caution should be exercised," it does not contraindicate breastfeeding. The decision should weigh maternal benefit against potential infant exposure, though clinical experience suggests low risk at standard doses.